{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:02:10Z","timestamp":1793073730885,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1245\/s10434-024-16013-1","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T16:02:39Z","timestamp":1724774559000},"page":"7978-7986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Decision Regret in Patients with Appendiceal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"31","author":[{"given":"Alexander","family":"Graves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid","family":"Sadjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaela","family":"Kosich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Fahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Pankratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiraz I.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-2919","authenticated-orcid":false,"given":"Alissa","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"issue":"1","key":"16013_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1245\/s10434-016-5588-2","volume":"24","author":"K Fournier","year":"2017","unstructured":"Fournier K, Rafeeq S, Taggart M, et al. Low-grade appendiceal mucinous neoplasm of uncertain malignant potential (LAMN-UMP): prognostic factors and implications for treatment and follow-up. Ann Surg Oncol. 2017;24(1):187\u201393. https:\/\/doi.org\/10.1245\/s10434-016-5588-2.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"16013_CR2","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00384-013-1714-9","volume":"28","author":"MGW van den Heuvel","year":"2013","unstructured":"van den Heuvel MGW, Lemmens VEPP, Verhoeven RHA, de Hingh IHJT. The incidence of mucinous appendiceal malignancies: a population-based study. Int J Colorectal Dis. 2013;28(9):1307\u201310. https:\/\/doi.org\/10.1007\/s00384-013-1714-9.","journal-title":"Int J Colorectal Dis"},{"issue":"10","key":"16013_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/jclinpath-2012-200843","volume":"65","author":"NJ Carr","year":"2012","unstructured":"Carr NJ, Finch J, Ilesley IC, et al. Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases. J Clin Pathol. 2012;65(10):919\u201323. https:\/\/doi.org\/10.1136\/jclinpath-2012-200843.","journal-title":"J Clin Pathol"},{"issue":"6","key":"16013_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/01.pap.0000194625.05137.51","volume":"12","author":"RK Pai","year":"2005","unstructured":"Pai RK, Longacre TA. Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification. Adv Anat Pathol. 2005;12(6):291\u2013311. https:\/\/doi.org\/10.1097\/01.pap.0000194625.05137.51.","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"16013_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jss.2012.12.040","volume":"183","author":"K McBride","year":"2013","unstructured":"McBride K, McFadden D, Osler T. Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis. J Surg Res. 2013;183(1):246\u201352. https:\/\/doi.org\/10.1016\/j.jss.2012.12.040.","journal-title":"J Surg Res"},{"issue":"1","key":"16013_CR6","doi-asserted-by":"publisher","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","volume":"2","author":"JM Foster","year":"2019","unstructured":"Foster JM, Sleightholm R, Patel A, et al. Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open. 2019;2(1):e186847. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6847.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"16013_CR7","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.ejso.2014.08.477","volume":"40","author":"C Seretis","year":"2014","unstructured":"Seretis C, Youssef H. Quality of life after cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: a systematic review. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2014;40(12):1605\u201313. https:\/\/doi.org\/10.1016\/j.ejso.2014.08.477.","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"4","key":"16013_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.suronc.2014.10.002","volume":"23","author":"LL Shan","year":"2014","unstructured":"Shan LL, Saxena A, Shan BL, Morris DL. Quality of life after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy for peritoneal carcinomatosis: a systematic review and meta-analysis. Surg Oncol. 2014;23(4):199\u2013210. https:\/\/doi.org\/10.1016\/j.suronc.2014.10.002.","journal-title":"Surg Oncol"},{"issue":"4","key":"16013_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0272989X03256005","volume":"23","author":"JC Brehaut","year":"2003","unstructured":"Brehaut JC, O\u2019Connor AM, Wood TJ, et al. Validation of a decision regret scale. Med Decis Mak Int J Soc Med Decis Mak. 2003;23(4):281\u201392. https:\/\/doi.org\/10.1177\/0272989X03256005.","journal-title":"Med Decis Mak Int J Soc Med Decis Mak"},{"issue":"3","key":"16013_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/jmg-2022-108733","volume":"60","author":"LA Gamble","year":"2023","unstructured":"Gamble LA, Grant RRC, Samaranayake S, et al. Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy. J Med Genet. 2023;60(3):241\u20136. https:\/\/doi.org\/10.1136\/jmg-2022-108733.","journal-title":"J Med Genet"},{"issue":"10","key":"16013_CR11","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1245\/s10434-021-10452-w","volume":"28","author":"A Deliere","year":"2021","unstructured":"Deliere A, Attai D, Victorson D, et al. Patients undergoing bilateral mastectomy and breast-conserving surgery have the lowest levels of regret: the WhySurg study. Ann Surg Oncol. 2021;28(10):5686\u201397. https:\/\/doi.org\/10.1245\/s10434-021-10452-w.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"16013_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1023\/a:1008821826499","volume":"8","author":"WL Ward","year":"1999","unstructured":"Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res. 1999;8(3):181\u201395. https:\/\/doi.org\/10.1023\/a:1008821826499","journal-title":"Qual Life Res"},{"issue":"6","key":"16013_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1177\/0272989X16636113","volume":"36","author":"MM Becerra P\u00e9rez","year":"2016","unstructured":"Becerra P\u00e9rez MM, Menear M, Brehaut JC, L\u00e9gar\u00e9 F. Extent and predictors of decision regret about health care decisions: a systematic review. Med Decis Mak Int J Soc Med Decis Mak. 2016;36(6):777\u201390. https:\/\/doi.org\/10.1177\/0272989X16636113.","journal-title":"Med Decis Mak Int J Soc Med Decis Mak"},{"key":"16013_CR14","unstructured":"Scoring Instructions. https:\/\/www.healthmeasures.net\/score-and-interpret\/calculate-scores\/scoring-instructions. Accessed 20 Jul 2024."},{"issue":"6","key":"16013_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.breast.2010.05.003","volume":"19","author":"J Gahm","year":"2010","unstructured":"Gahm J, Wickman M, Brandberg Y. Bilateral prophylactic mastectomy in women with inherited risk of breast cancer\u2014prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast Edinb Scotl. 2010;19(6):462\u20139. https:\/\/doi.org\/10.1016\/j.breast.2010.05.003.","journal-title":"Breast Edinb Scotl"},{"issue":"4","key":"16013_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1006\/pmed.1995.1066","volume":"24","author":"ME Stefanek","year":"1995","unstructured":"Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F. Predictors of and satisfaction with bilateral prophylactic mastectomy. Prev Med. 1995;24(4):412\u20139. https:\/\/doi.org\/10.1006\/pmed.1995.1066.","journal-title":"Prev Med"},{"key":"16013_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_360970","volume":"42","author":"ME Tesch","year":"2022","unstructured":"Tesch ME, Partridge AH. Treatment of breast cancer in young adults. Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet. 2022;42:1\u201312. https:\/\/doi.org\/10.1200\/EDBK_360970.","journal-title":"Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet"},{"key":"16013_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13023-021-01723-6","volume":"16","author":"YL Lin","year":"2021","unstructured":"Lin YL, Xu DZ, Li XB, et al. Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines. Orphanet J Rare Dis. 2021;16:85. https:\/\/doi.org\/10.1186\/s13023-021-01723-6.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"16013_CR19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S1470-2045(23)00396-0","volume":"24","author":"SL Aronson","year":"2023","unstructured":"Aronson SL, Lopez-Yurda M, Koole SN, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial. Lancet Oncol. 2023;24(10):1109\u201318. https:\/\/doi.org\/10.1016\/S1470-2045(23)00396-0.","journal-title":"Lancet Oncol"},{"issue":"2","key":"16013_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366. https:\/\/doi.org\/10.1016\/S1470-2045(20)30599-4.","journal-title":"Lancet Oncol"},{"issue":"8","key":"16013_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/pon.997","volume":"15","author":"MS Walker","year":"2006","unstructured":"Walker MS, Zona DM, Fisher EB. Depressive symptoms after lung cancer surgery: their relation to coping style and social support. Psychooncology. 2006;15(8):684\u201393. https:\/\/doi.org\/10.1002\/pon.997.","journal-title":"Psychooncology"},{"issue":"9","key":"16013_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/sj.bjc.6603091","volume":"94","author":"US Lehto","year":"2006","unstructured":"Lehto US, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P. Baseline psychosocial predictors of survival in localised breast cancer. Br J Cancer. 2006;94(9):1245\u201352. https:\/\/doi.org\/10.1038\/sj.bjc.6603091.","journal-title":"Br J Cancer"},{"issue":"8","key":"16013_CR23","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/ncponc1134","volume":"5","author":"Y Chida","year":"2008","unstructured":"Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol. 2008;5(8):466\u201375. https:\/\/doi.org\/10.1038\/ncponc1134.","journal-title":"Nat Clin Pract Oncol"},{"issue":"22","key":"16013_CR24","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1002\/cncr.24561","volume":"115","author":"JR Satin","year":"2009","unstructured":"Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115(22):5349\u201361. https:\/\/doi.org\/10.1002\/cncr.24561.","journal-title":"Cancer"},{"issue":"6","key":"16013_CR25","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00520-017-4005-0","volume":"26","author":"E Pinto","year":"2018","unstructured":"Pinto E, Cavallin F, Saadeh LM, et al. Potential curability and perception of received information in esophageal cancer patients. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2018;26(6):1807\u201314. https:\/\/doi.org\/10.1007\/s00520-017-4005-0.","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"Suppl 5","key":"16013_CR26","doi-asserted-by":"publisher","first-page":"S654","DOI":"10.21037\/jtd.2019.02.34","volume":"11","author":"E Pinto","year":"2019","unstructured":"Pinto E, Cavallin F, Scarpa M. Psychological support of esophageal cancer patient? J Thorac Dis. 2019;11(Suppl 5):S654\u201362. https:\/\/doi.org\/10.21037\/jtd.2019.02.34.","journal-title":"J Thorac Dis"},{"issue":"11","key":"16013_CR27","doi-asserted-by":"publisher","first-page":"9461","DOI":"10.1007\/s00432-023-04753-8","volume":"149","author":"A Kiemen","year":"2023","unstructured":"Kiemen A, Czornik M, Weis J. How effective is peer-to-peer support in cancer patients and survivors? A systematic review. J Cancer Res Clin Oncol. 2023;149(11):9461\u201385. https:\/\/doi.org\/10.1007\/s00432-023-04753-8.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"16013_CR28","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1007\/s00520-020-05719-z","volume":"28","author":"F Mols","year":"2020","unstructured":"Mols F, Tomalin B, Pearce A, Kaambwa B, Koczwara B. Financial toxicity and employment status in cancer survivors. A systematic literature review. Support Care Cancer. 2020;28(12):5693\u2013708. https:\/\/doi.org\/10.1007\/s00520-020-05719-z.","journal-title":"Support Care Cancer"},{"issue":"5","key":"16013_CR29","doi-asserted-by":"publisher","first-page":"djv370","DOI":"10.1093\/jnci\/djv370","volume":"108","author":"SY Zafar","year":"2016","unstructured":"Zafar SY. Financial toxicity of cancer care: it\u2019s time to intervene. J Natl Cancer Inst. 2016;108(5):djv370. https:\/\/doi.org\/10.1093\/jnci\/djv370.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"16013_CR30","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1245\/s10434-020-08379-9","volume":"27","author":"M Leimk\u00fchler","year":"2020","unstructured":"Leimk\u00fchler M, Hentzen JEKR, Hemmer PHJ, et al. Systematic review of factors affecting quality of life after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2020;27(10):3973\u201383. https:\/\/doi.org\/10.1245\/s10434-020-08379-9.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"16013_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.suronc.2015.11.003","volume":"25","author":"S Malfroy","year":"2016","unstructured":"Malfroy S, Wallet F, Maucort-Boulch D, et al. Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: risk factors for ICU admission and morbidity prognostic score. Surg Oncol. 2016;25(1):6\u201315. https:\/\/doi.org\/10.1016\/j.suronc.2015.11.003.","journal-title":"Surg Oncol"},{"issue":"11","key":"16013_CR32","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1016\/j.ejso.2021.05.019","volume":"47","author":"M Lomnytska","year":"2021","unstructured":"Lomnytska M, Karlsson E, Jonsdottir B, et al. Peritoneal cancer index predicts severe complications after ovarian cancer surgery. Eur J Surg Oncol. 2021;47(11):2915\u201324. https:\/\/doi.org\/10.1016\/j.ejso.2021.05.019.","journal-title":"Eur J Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16013-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16013-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16013-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T14:11:46Z","timestamp":1728569506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16013-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["16013"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16013-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Bridget Fahy has stock ownership in the following companies: Align Technology, Inc.; Biogen Inc.; BRISTOL-MYERS SQUIBB CO COM; DexCom, Inc.; EDITAS MEDICINE INC COM; Fulgent Genetics, Inc.; GoodRx Holdings, Inc. Class A; Guardant Health, Inc.; Globus Medical Inc Class A; HCA Healthcare Inc; IDEXX LABORATORIES INC COM USD0.10; Intuitive Surgical, Inc.; MASIMO CORP; Moderna, Inc.; Neurocrine Biosciences, Inc.; Repligen Corporation; ResMed Inc.; Seagen, Inc.; STAAR Surgical Company; Shockwave Medical, Inc.; TELADOC HEALTH INC COM; UnitedHealth Group Incorporated; and Veeva Systems Inc Class A.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}